Tag: HCPCS codes
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
How the FDA Monitors Generic Drug Safety After Approval
Dec, 7 2025
Exploring Vibramycin Alternatives: A Look at Other Options
Mar, 20 2025
Goldenseal and Metformin Interaction Risks for Blood Sugar Control
Dec, 30 2025
Pentosan Polysulfate: Emerging Role in Joint Disorder Therapy
Oct, 18 2025
Corticosteroid Injections for Joint Pain: What They Do, How Long They Last, and When to Avoid Them
Jan, 5 2026